 |
Background: Papaya
is a tropical-subtropical crop that is grown in back yards
as well as in large-scale farms, it produces year round, many
people in lesser-developed countries eat it, and it is arguably
one of the most nutritious fruit crops, rich in vitamins A
and C. The crop is easily grown, except for the fact that
it can be severely infected by papaya ringspot virus (PRSV).
PRSV is the most damaging virus of papaya worldwide. Trees
infected at a young stage almost never bear fruit, and the
fruit of trees that do bear show characteristics ringspots,
can be deformed, and generally have lower sugar contents.
Yields of infected trees are severely affected. Papaya in
Bangladesh, like nearly all tropical countries, are severely
affected by PRSV; in fact, PRSV is the main factor that limits
papaya production in Bangladesh. The long-term goal of this
project is to increase the health status of people in Bangladesh
by making PRSV-resistant transgenic papaya readily available
and affordable to households and farmers. Incidence to night
blindness is over 3% of the population- all due to lack of
a good source of vitamin A. This could be solved through increase
consumption of this delicious fruit.
The dramatic impact that PRSV can have
on a papaya industry was recently shown in Hawaii. Up until
1992, Hawaii enjoyed steady production of papaya with greater
then 80% of their crop being exported out of state. In 1992,
Hawaii accounted for more then 75% of the papaya imported
to mainland US. In May 1992, PRSV was discovered in Puna,
the main papaya growing area where 95% of Hawaii’s papaya
was being grown, and by 1995, PRSV was widespread throughout
the area. The papaya production steadily dropped from 53 millions
pounds in 1992 to 26 million pounds in 1998. The papaya industry
in Hawaii was on the way to virtual extinction. However, the
impact of PRSV resistant transgenic papaya on restoring papaya
production to the devastated areas is also dramatically shown
in Hawaii. Using the concept of pathogen-derived resistance,
a transgenic papaya was developed in 1991 that showed resistance
to PRSV strains in Hawaii. Initial field trials in 1992 showed
that the transgenic papaya was resistant under field conditions
and that the papaya had excellent horticultural properties.
The transgenic cultivars ‘Rainbow’ and ‘SunUp’
were developed and showed excellent resistance in field trials
in 1995. These cultivars received regulatory approval and
licenses were obtained for commercial release to growers in
Hawaii in May 1998. The transgenic papaya has replaced infected
papaya in Puna and other areas of Hawaii, such that the production
of papaya in Hawaii is predicted to reach 50 million pounds
in 2001, only three years after the release of the transgenic
papaya in Hawaii.
In many tropical regions, PRSV is already
well established and thus households or farmers cannot routinely
grow healthy, high-yielding papaya. This is the case in Northeast
Thailand and in Bangladesh. It has been suggested that in
Bangladesh PRSV causes a yield reduction of 70-100%. Unfortunately,
efforts to control PRSV through development of resistant cultivars
have failed because resistance is not known in papaya (Carica
papaya) and efforts to transfer resistant genes from other
Carica species have failed because the resulting crosses are
sterile. Cross protection, a form of immunizing plants with
a mild strain of papaya ringspot virus to protect against
infection with a severe strain, showed some measure of success
in Hawaii. However, the mild mutant isolate developed in Hawaii
could not provide sustained control of PRSV in other countries.
The seriousness of the PRSV in Bangladesh has also prompted
cross protection research as a possible means to control PRSV.
Tolerant cultivars developed for Thailand are being used in
Northeast Thailand. However, these cultivars become infected
by PRSV and seeds must be produced under stringent conditions
and progenies continually screened for tolerance because the
multigenic nature of the tolerance trait makes it difficult
to transfer to progenies. Furthermore, data from Thailand
demonstrated that production by PRSV-resistant papaya is over
10 times greater than lines bred for tolerance.
The control of PRSV in Hawaii clearly shows
that the pathogen-derived resistance approach is the most
effective way to control PRSV. Bangladesh as a developing
country requires biosafety and regulatory standards for the
introduction, testing, and ultimately release of transgenics.
Though papaya is not within the mandated crops, CIMMYT Bangladesh
is offering to its partners at Cornell University and USDA,
Hilo Hawaii, project management and leadership in biosafety
and regulatory issues, using the current CIMMYT Agronomist
with 20 years of experience in Bangladesh.
Objectives:
- Characterize PRSV isolates in Bangladesh,
- Engineer CP transgene constructs of
representative PRSV isolates from Bangladesh,
- Develop transgenic papaya with the PRSV
transgene constructs and identify R0 lines that are resistant
to PRSV,
- Evaluate progenies of R0 plants for
resistance and horticultural characteristics, and select
promising lines for advanced testing,
- Obtain regulatory and intellectual property
rights approval for selected lines, and
- Increase the seeds of selected transgenic
papaya lines or cultivars and subsequently release seeds
to farmers and households.
Target Germplasm: Shahee
variety of papaya released by the Bangladesh Agriculture Research
Institute
Gene(s): Coat protein gene
of the virus
Partner(s): Cornell University,
Bangladesh Agriculture Research Institute (BARI), Bangabandhu
Sheikh Mozibur Rahman Agricultural University (BSMRAU)
Status: Viral strains
have been collected within Bangladesh and are being studied
for homology to a synthetic gene being produced in the USDA
lab in Hawaii. If found homologous, then transformation with
the synthetic gene will be made and tested. CIMMYT has assisted
the Bangladesh government in developing biosafety and regulation
of transgenics in collaboration with USAID-funded projects
ABSP-II and PBS within the country.
Back to Genetic
Resources Unit | Transgenic
Research and Statements
Top
|